SAN FRANCISCO and BERLIN, March 03, 2026 (GLOBE NEWSWIRE) -- T-knife Therapeutics, Inc., a biopharmaceutical company developing next-generation T cell therapies to fight cancer, today announced the ...

(MENAFN- GlobeNewsWire - Nasdaq) - Phase 1 ATLAS trial to evaluate TK-6302 in patients with advanced PRAME-positive solid tumors authorized for initiation SAN FRANCISCO and BERLIN, March 03, 2026 ...

An urgent recall has been issued for a toy sold in TK Maxx and Homesense after it was found to contain 'trace levels of asbestos'. The retailers are urging anyone who has bought the affected toy to ...

-Phase 1 ATLAS trial to evaluate TK-6302 in patients with advanced PRAME-positive solid tumors authorized for initiation SAN FRANCISCO and BERLIN, March 03, 2026 (GLOBE NEWSWIRE) -- T-knife ...

Robin has worked as a credit cards, editor and spokesperson for over a decade. Prior to Forbes Advisor, she also covered credit cards and related content for other national web publications including ...

Don’t start with moon shots. by Thomas H. Davenport and Rajeev Ronanki In 2013, the MD Anderson Cancer Center launched a “moon shot” project: diagnose and recommend treatment plans for certain forms ...